Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2003-11-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BBADIS.2003.09.008PMID 14636952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extensive Association Analysis Between Polymorphisms of PON Gene Cluster With Coronary Heart Disease in Chinese Han Population

  2003cited by this paper
• Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice

  2002cited by this paper
• Gene : environment interaction in lipid metabolism and effect on coronary heart disease risk

  2002cited by this paper
• Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families.

  2002cited by this paper
• PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.

  2001cited by this paper
• Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype?

  2001cited by this paper
• A new statistical method for haplotype reconstruction from population data.

  2001cited by this paper
• Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations.

  2001cited by this paper
• Genetic variations of the paraoxonase gene in patients with coronary artery disease.

  2001cited by this paper
• Paraoxonase promoter polymorphism T(–107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease

  2001cited by this paper
• Is paraoxonase-3 another hdl-associated protein protective against atherosclerosis?

  2001cited by this paper
• Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

  2001cited by this paper
• Paraoxonase and Atherosclerosis

  2001cited by this paper
• The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients

  2001cited by this paper
• Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids.

  2001cited by this paper
• Is Paraoxonase-3 Another HDL-Associated Protein Protective Against Atherosclerosis?

  2001cited by this paper
• Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein*

  2001cited by this paper
• A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression.

  2000cited by this paper
• Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations.

  2000cited by this paper
• Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.

  2000cited by this paper
• Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases.

  2000cited by this paper
• Macrophage Foam Cell Formation During Early Atherogenesis Is Determined by the Balance Between Pro-Oxidants and Anti-Oxidants in Arterial Cells and Blood Lipoproteins

  1999cited by this paper
• Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

  1998cited by this paper
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

  1998cited by this paper
• DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.

  1998cited by this paper
• The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.

  1998cited by this paper
• Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.

  1998cited by this paper
• Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.

  1998cited by this paper
• The Arg192 isoform of paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese

  1997cited by this paper
• The regulation of splice-site selection, and its role in human disease.

  1997cited by this paper
• Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

  1997cited by this paper
• The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

  1996cited by this paper
• The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

  1996cited by this paper
• The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.

  1996cited by this paper
• Confidence Intervals for Measures of Interaction

  1996cited by this paper
• Increased Activation of the Haemostatic System in Men at High Risk of Fatal Coronary Heart Disease

  1996cited by this paper
• Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

  1995cited by this paper
• HDL, its enzymes and its potential to influence lipid peroxidation.

  1995cited by this paper
• Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.

  1995cited by this paper
• High-throughput genotyping using horizontal polyacrylamide gels with wells arranged for microplate array diagonal gel electrophoresis (MADGE).

  1995cited by this paper
• HDL, its enzymes and its potential to influence lipid peroxidation

  1995cited by this paper
• Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification.

  1993cited by this paper
• The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.

  1993cited by this paper
• The molecular basis of the human serum paraoxonase activity polymorphism

  1993cited by this paper
• Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.

  1991cited by this paper
• Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

  1991cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.

  1986cited by this paper
• Nonuniform recombination within the human beta-globin gene cluster.

  1984cited by this paper
• The human serum paraoxonase/arylesterase polymorphism.

  1983cited by this paper
• The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification

  1982cited by this paper

• Molecular Structure of Paraoxonase-1 and Its Modifications in Relation to Enzyme Activity and Biological Functions—A Comprehensive Review

  2024cites this paper
• Cardioprotective Role for Paraoxonase-1 in Chronic Kidney Disease

  2022cites this paper
• Association and Haplotype Analysis of the PON1, ITGB3 and CYP3A4 Genes, Strong Candidates for Familial Coronary Artery Disease Susceptibility

  2022cites this paper
• Insights into the role of paraoxonase 2 in human pathophysiology

  2022cites this paper
• Insights into the role of paraoxonase 2 in human pathophysiology

  2022cites this paper
• Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review

  2021cites this paper
• The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases

  2021cites this paper
• Genetic associations and serum paraoxonase levels with atherosclerosis in western Iranian patients

  2020cites this paper
• Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery

  2019cites this paper
• Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease

  2019cites this paper
• Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway.

  2019cites this paper
• Association between PON 1 L 55 M polymorphisms and risk of coronary heart disease : a meta-analysis based on 46 case-control studies

  2019cites this paper
• Preliminary Analysis of PON3 rs2375003 Polymorphism in Pakistani Patients with Coronary Artery Disease

  2019cites this paper
• Loughborough University Institutional Repository Paraoxonase 1 GENE polymorphisms contribute to coronary artery disease risk

  2018cites this paper
• Associations of the PON1 rs854560 polymorphism with plasma lipid levels: a meta-analysis

  2018cites this paper
• PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.

  2018cites this paper
• Paraoxonase 1 Gene Polymorphisms (Q192R and L55M) Are Associated with Coronary Artery Disease Susceptibility in Asian Indians

  2018cites this paper
• GENETIC POLYMORPHISM OF PARAOXONASE 3 GENE ALA99ALA IN ADJAANDMAHIETHNIC GROUPS IN BENIN.

  2017cites this paper
• Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score

  2016cites this paper
• Effects of paraoxonase 1 gene polymorphisms on heart diseases

  2016cites this paper
• Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.

  2015cites this paper
• Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk

  2015cites this paper
• The association of the PON 1 Q 192 R polymorphism with coronary heart disease : findings from the British Women ' s Heart and Health cohort study and a meta-analysis

  2015influential citation
• Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity

  2014cites this paper
• Paraoxonase 2 Gene (Cys311-Ser) Polymorphism and the Risk of Coronary Artery Disease

  2014cites this paper
• Exploring the Role of Paraoxonases in the Pathogenesis of Coronary Artery Disease: A Systematic Review

  2014cites this paper
• Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?

  2014cites this paper
• The influence of gene polymorphisms, modifiable lifestyle factors, and toxicants on the protective effects of the paraoxonase genes

  2014cites this paper
• Association of Polymorphism of Ser311cys Paraoxonase-2 Gene with Type 2 Diabetes Mellitus in Iran

  2013cites this paper
• Association of Paraoxonase1 Gene Q192R Polymorphism and Apolipoprotein B in Asian Indian Women with Coronary Artery Disease Risk

  2013cites this paper
• Rôle de la Paraoxonase (PON1) dans l'activité anti-inflammatoire de HDL et sa modulation par la diète

  2013cites this paper
• Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion

  2013cites this paper
• PON1 gene polymorphisms and plasma PON1 activities in Takayasu's arteritis disease.

  2013cites this paper
• Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities.

  2013cites this paper
• Paraoxonase-1 55 LL Genotype Is Associated with No ST-Elevation Myocardial Infarction and with High Levels of Myoglobin

  2012cites this paper
• Association between diet and polymorphisms in individuals with statin-controlled dyslipidaemia grouped according to oxidative stress biomarkers

  2012cites this paper
• Microsoft Word - Robciuc - THL Word Template.docx

  2012cites this paper
• SERUM PARAOXONASE PHENOTYPE DISTRIBUTION IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION AND ITS RELATIONSHIP TO HOMOCYSTEINE AND OXIDIZED LOW-DENSITY LIPOPROTEIN

  2012cites this paper
• Role of angiopoietin-like 3 and 4 in triacylglycerol metabolism : from population studies to molecular mechanisms of action

  2012cites this paper
• Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.

  2011cites this paper
• Association of paraoxonase gene polymorphisms with sperm parameters.

  2011cites this paper
• O Papel dos Polimorfismos Genéticos na Doença Cardíaca Isquémica.

  2011cites this paper
• Interactive effect of cigarette smoking and gene variants for predisposing to cardiovascular disease.

  2010cites this paper
• Paraoxonase Gene Polymorphisms and Aortic Calcification

  2010cites this paper
• Paraoxonase activity in athletic adolescents.

  2010cites this paper
• Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies.

  2010cites this paper
• Paraoxonase 1 polymorphisms as the risk factor of coronary heart disease in a Thai population

  2010cites this paper
• The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study

  2010cites this paper
• Human paraoxonase 2

  2010cites this paper
• Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors.

  2009cites this paper
• Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes

  2009cites this paper
• Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.

  2009cites this paper
• Cardiovascular event risk: high-density lipoprotein and paraoxonase.

  2009cites this paper
• PON1 is a longevity gene: results of a meta-analysis.

  2009cites this paper
• Polimorfismos no gene paraoxonase 1 como preditores de eventos cardiovasculares em pacientes com doença coronária estável

  2009cites this paper
• Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.

  2008cites this paper
• The Ser311Cys variation in the paraoxonase 2 gene increases the risk of type 2 diabetes in northern Chinese

  2008cites this paper
• [Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction].

  2008cites this paper
• Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

  2008cites this paper
• Purification of Human Serum Paraoxonase and Effect of Acetylsalicylic Acid on Paraoxonase Activity

  2008cites this paper
• The paraoxonase gene polymorphism in stroke patients and lipid profile

  2008cites this paper
• Asociación de los polimorfismos de la paraoxonasa 1 y la paraoxonasa 2 con el riesgo de infarto agudo de miocardio

  2008cites this paper
• Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities study.

  2007cites this paper
• Human serum paraoxonase concentration predicts cardiovascular mortality in hemodialysis patients.

  2007cites this paper
• Study of the Relationship between Gene Polymorphisms of Paraoxonase 2 and Stroke in a Chinese Population

  2007cites this paper
• Paraoxonase and cardiovascular disease: actions and interactions.

  2006cites this paper
• Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile.

  2006cites this paper
• Paraoxonase gene polymorphisms and haplotype analysis in a stroke population

  2006cites this paper
• Genetic variants predisposing to cardiovascular disease

  2006cites this paper
• The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M400489-JLR200

  2005cites this paper
• Evaluation of the Paraoxonases as Candidate Genes for Stroke: Gln192Arg Polymorphism in the Paraoxonase 1 Gene Is Associated With Increased Risk of Stroke

  2005cites this paper
• A carbohydrate-rich diet reduces LDL size in QQ homozygotes for the Gln192Arg polymorphism of the paraoxonase 1 gene

  2005cites this paper
• EFFECTS OF OXIDATIVE STRESS CAUSED BY ACUTE AND REGULAR EXERCISE ON LEVELS OF SOME SERUM METABOLITES AND THE ACTIVITIES OF PARAOXONASE AND ARYLESTERASE

  2005cites this paper
• Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people

  2005cites this paper
• The Role of Paraoxonase 1 Activity in Cardiovascular Disease

  2004cites this paper
• Paraoxonase 1 activity, concentration and genotype in cardiovascular disease

  2004cites this paper
• The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis

  2004influential citation
• Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?

  2004cites this paper
• New insight on the molecular mechanisms of high-density lipoprotein cellular interactions

  2004cites this paper
• Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes

  2004cites this paper
• Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.

  2004cites this paper